Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Severe hypoxia drives loss of ST6GAL1-mediated α2,6-sialylation in the epicardial secretome impairing angiogenic activity. | Biol Open | 2026 | 42052876 | PubTator, text mining | PubMed |
| Labeling and detecting human milk oligosaccharides through ST3Gal3 incorporation of azido sialic acid and gel electrophoresis. | Glycobiology | 2026 | 42011941 | PubTator, text mining | PubMed |
| Targeting cancer cell sialylation with monosaccharide analogues modulates EGFR in colorectal cancer cells. | Biochim Biophys Acta Gen Subj | 2026 | 42002163 | PubTator, text mining | PubMed |
| d-Pinitol Rescues Osteoblast Differentiation From Tumor Necrosis Factor-Alpha-Mediated Suppression via β-Galactoside α-2,6-Sialyltransferase 1 Induction. | Cell Biochem Funct | 2026 | 41952270 | PubTator, text mining | PubMed |
| Anti-hepatocellular carcinoma activity of Jacaranda mimosifolia through experimental validation and network pharmacology. | PLoS One | 2026 | 41931506 | PubTator, text mining | PubMed |
| ST6Gal1 influences the esophageal squamous cell carcinoma resistance to IFN-γ by regulating the expression of IFN-γ receptor 1. | Biochim Biophys Acta Gen Subj | 2026 | 41895538 | PubTator, text mining | PubMed |
| Targeting sialic acid metabolism: a therapeutic strategy against gastric cancer driven by WZ35. | Cell Oncol (Dordr) | 2026 | 41870836 | PubTator, text mining | PubMed |
| PRAS40 activates the IRE1α-XBP-1-mediated unfolded protein response to exacerbate colorectal cancer by enhancing ST6Gal1-dependent α-2, 6 sialylation of GRP78. | Neoplasia | 2026 | 41865639 | PubTator, text mining | PubMed |
| Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer. | Cell Rep Med | 2026 | 41850238 | PubTator, text mining | PubMed |
| Exploring the role of sialidases in Galectin-1-associated resistance to cancer therapies. | Biochim Biophys Acta Gen Subj | 2026 | 41831659 | PubTator, text mining | PubMed |
| Tissue-Based Transcriptomic Profiling of Gastrointestinal Graft Versus Host Disease Reveals Immune and MicroRNA Dysregulation. | Int J Mol Sci | 2026 | 41828729 | PubTator, text mining | PubMed |
| Galactose tolerance in adults with classical galactosaemia. Considering the gaps. | Mol Genet Metab Rep | 2026 | 41798075 | PubTator, text mining | PubMed |
| Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression. | Front Immunol | 2026 | 41789075 | PubTator, text mining | PubMed |
| Integrated network toxicology and multi-omics analysis reveals the role of tobacco-specific carcinogen NNK in idiopathic pulmonary fibrosis pathogenesis. | Respir Res | 2026 | 41764494 | PubTator, text mining | PubMed |
| The Role of Glycan Structures in Modulating GM-CSF Bioactivity: Insights from Glycoengineering. | bioRxiv | 2026 | 41756846 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Profile Associated with Sub-Subtype A6 and CRF63-02A6 HIV-1 Strain Infection. | Viruses | 2026 | 41754547 | PubTator, text mining | PubMed |
| Combinations of Favipiravir with Doxycycline, Azithromycin or Ivermectin Exert Synergistic Effects Against Influenza A H3N2 Virus Replication. | Pathogens | 2026 | 41754422 | PubTator, text mining | PubMed |
| Antigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients by Multiple TLC Overlay Assay and IR-MALDI Mass Spectrometry. | Cancers (Basel) | 2026 | 41749917 | PubTator, text mining | PubMed |
| High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. | Elife | 2026 | 41725518 | PubTator, text mining | PubMed |
| Genome-Wide Association Study (GWAS)-Derived Type 2 Diabetes Risk Variants in Gestational Diabetes Mellitus: Evidence From North India. | Cureus | 2026 | 41710845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=2